A coalition of CBD producing companies, ONE HEMP, whose objective is to mobilize Congress and the Food and Drug Administration (FDA), the American food authority, presented to American authorities a study showing that a maximum dose of 70 milligrams of CBD per day is safe for healthy adults. The study also showed that a maximum dose of 160 milligrams per day is safe for healthy adults who are not trying to conceive, are not pregnant, or breastfeeding.
The study was submitted following a request for information from committees in the House and Senate and was specifically designed to address concerns previously expressed by the FDA that CBD is potentially harmful to the liver and reproductive health.
In a statement, Dr. Rayetta G. Henderson, principal investigator at ToxStrategies LLC, which conducted the study, said the research found that the upper limits of CBD consumption suggested for healthy adults “closely match the recommendations made by major regulatory bodies”, including Health Canada which places it at 200mg per day, the Therapeutic Goods Administration from Australia which places it at 60mg per day and Food Standards Agency from the United Kingdom which places it at 70mg/day.
Marcel Bonn-Miller, Ph.D., chief scientific officer of Charlotte’s Web and a member of the research team, said the study “will help inform legislators and regulators as they determine data requirements.” manufacturing and labeling of food supplements containing CBD”.
“Implementing science-based safety limits is essential to protect consumers. This research also supports ONE HEMP’s recommendations for accurate product labeling and ultimately holding CBD companies accountable for manufacturing and selling safe, quality products.” Bonn-Miller said in a press release.
Charlotte’s Web, known for its shared history with Charlotte Figi, is a founding member of ONE HEMP, whose goal is to work toward higher regulatory standards, including independent third-party testing and accurate labeling , the company said in a press release.
Jared Stanley, co-founder and COO of Charlotte’s Web, said the CBD market needs “clarity and stability” and “it is time for Congress to clarify the FDA’s mandate and definitively regulate the CBD products as dietary supplements once and for all.”
The study submitted by ONE HEMP was published online August 25 in the journal Regulatory Toxicology and Pharmacology.
